HDAC9 and cancer: We generated a series of PROTACs based on CI‐994, a class I HDAC inhibitor with high selectivity against HDACs 1–3 [28], using the E3 ligase VHL (JPS016) or the IAP ligand (JPS026), and they were shown to induce apoptosis in cancer cells [23, 26, 29].